T-CELL/HISTIOCYTE RICH LYMPHOMA
Clinical trials for T-CELL/HISTIOCYTE RICH LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new T-CELL/HISTIOCYTE RICH LYMPHOMA trials appear
Sign up with your email to follow new studies for T-CELL/HISTIOCYTE RICH LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New 'Living Drug' trial offers hope for lymphoma patients out of options
Disease control Recruiting nowThis is a first-in-human study testing the safety and early effectiveness of a new, single-infusion CAR-T cell therapy called SynKIR-310. It is for adults with B-cell non-Hodgkin lymphoma that has come back or not responded to at least two prior treatments, including other CAR-T …
Matched conditions: T-CELL/HISTIOCYTE RICH LYMPHOMA
Phase: PHASE1 • Sponsor: Verismo Therapeutics • Aim: Disease control
Last updated Apr 03, 2026 14:43 UTC
-
First human trial tests promising pill for tough blood cancers
Disease control Recruiting nowThis early-stage study is testing a new oral medication called SGR-1505 in adults with advanced B-cell cancers that have returned or stopped responding to previous treatments. The main goal is to find the highest safe dose and understand how the drug affects the body. Researchers…
Matched conditions: T-CELL/HISTIOCYTE RICH LYMPHOMA
Phase: PHASE1 • Sponsor: Schrödinger, Inc. • Aim: Disease control
Last updated Apr 03, 2026 14:42 UTC